当前位置:首页 - 行情中心 - 东方生物(688298) - 财务分析 - 资产负债表

东方生物

(688298)

  

流通市值:45.02亿  总市值:45.02亿
流通股本:2.02亿   总股本:2.02亿

资产负债表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
流动资产:
  货币资金2,250,746,035.952,449,726,944.072,430,961,144.022,500,715,509.52
  交易性金融资产149,732,961.97122,590,377.71211,686,988.44316,732,715.07
  应收票据及应收账款178,095,948.16213,667,145.52226,662,055.27193,388,585.06
  其中:应收票据276,445607,735949,6101,849,025
        应收账款177,819,503.16213,059,410.52225,712,445.27191,539,560.06
  预付款项27,078,491.8924,754,953.2633,272,652.4536,063,307.39
  其他应收款合计11,403,120.6712,789,433.5910,443,165.2910,855,213.95
  存货293,914,988.07309,862,572.02332,054,222.77313,048,970.1
  其他流动资产127,371,292.76122,864,246.89120,686,454.27116,499,255.51
  流动资产合计3,038,342,839.473,256,255,673.063,365,766,682.513,487,303,556.6
非流动资产:
  长期股权投资17,152,335.9617,624,764.1818,339,883.4319,144,645.93
  其他非流动金融资产30,294,872.7530,230,070.2430,183,130.5530,122,602.91
  固定资产1,575,727,151.291,606,681,271.821,677,677,541.831,512,291,030.11
  在建工程1,021,385,088.211,009,683,512.161,112,445,250.681,242,036,323.01
  使用权资产24,978,708.6328,231,207.5137,104,514.6540,617,805.32
  无形资产866,709,657.94883,878,063.33930,147,387.62651,719,741.64
  商誉00--
  长期待摊费用36,750,161.6142,120,277.5447,881,124.8850,588,936.91
  递延所得税资产250,729,013.15256,115,208.13272,743,992.7268,595,531.72
  其他非流动资产30,981,074.838,125,779.3515,434,091.52308,200,962.78
  非流动资产合计3,854,708,064.373,882,690,154.264,141,956,917.864,123,317,580.33
  资产总计6,893,050,903.847,138,945,827.327,507,723,600.377,610,621,136.93
流动负债:
  短期借款134,963,005.86130,554,844.44103,259,685167,962,333.89
  交易性金融负债00--
  应付票据及应付账款386,663,478.56481,404,930.31479,039,935.78452,982,699
  其中:应付票据30,994,530.837,258,712.833,628,182-
        应付账款355,668,947.73474,146,217.48475,411,753.78452,982,699
  预收款项617,786.05619,266.05--
  合同负债27,716,122.1637,524,600.6633,251,251.1532,142,326.17
  应付职工薪酬41,828,794.3465,255,953.7941,969,804.9935,913,612.4
  应交税费5,376,819.2912,181,140.546,200,832.435,954,684.8
  其他应付款合计82,968,859.4392,385,589.02106,516,944.59114,524,887.06
  一年内到期的非流动负债121,446,825.7811,120,079.7815,110,511.2916,884,465.38
  其他流动负债737,711816,233.581,226,583.691,200,613.34
  流动负债合计802,319,402.47831,862,638.17786,575,548.92827,565,622.04
非流动负债:
  长期借款45,014,744.5158,990,000159,093,750114,133,950
  租赁负债24,681,014.5625,297,165.1228,942,424.3930,179,874.41
  长期应付款4,565,435.515,071,507.327,901,664.667,968,133.12
  长期应付职工薪酬-0--
  预计负债5,743,6475,943,7986,017,3826,192,900
  递延收益25,842,325.3626,062,461.5826,324,176.3826,544,312.6
  递延所得税负债8,607.7243,066.1754,067.22109,535.33
  非流动负债合计105,855,774.65221,407,998.19228,333,464.65185,128,705.46
  负债合计908,175,177.121,053,270,636.361,014,909,013.571,012,694,327.5
所有者权益(或股东权益):
  实收资本(或股本)201,600,000201,600,000201,600,000201,600,000
  资本公积397,975,635.81397,885,635.81397,885,635.81397,885,635.81
  减:库存股326,942,031.65326,942,031.65326,942,031.65276,947,754.62
  其他综合收益21,164,461.9326,119,880.8333,112,499.3333,076,055.46
  盈余公积84,000,00084,000,00084,000,00084,000,000
  未分配利润5,516,209,500.065,610,052,629.235,971,018,692.046,020,553,040.36
  归属于母公司股东权益合计5,894,007,566.155,992,716,114.226,360,674,795.536,460,166,977.01
  少数股东权益90,868,160.5792,959,076.74132,139,791.27137,759,832.42
  股东权益合计5,984,875,726.726,085,675,190.966,492,814,586.86,597,926,809.43
  负债和股东权益合计6,893,050,903.847,138,945,827.327,507,723,600.377,610,621,136.93
公告日期2026-04-292026-04-292025-10-312025-08-29
审计意见(境内)标准无保留意见
TOP↑